Skip to main content
. 2022 Apr 1;13:858722. doi: 10.3389/fimmu.2022.858722

Table 1.

Demographic and clinical data of subjects from whom biopsies were obtained.

Healthy (n = 20) Asthmatics (n = 16)
Age (years) a 63.7 (46–78) 52.4 (26–79)
Gender (female) (%) 8 (40.0) 6 (37.5)
Atopy (%) 0 (0.0) 3 (18.8)
Smoking history
 Current (%) 4 (20.0) 4 (25.0)
 Ex-smoker (%) 4 (20.0) 7 (43.7)
 Non-smoker (%) 12 (60.0) 5 (31.3)
Bronchiectasis (%) NA 2 (12.5)
Chronic bronchitis (%) NA 2 (12.5)
Immunological disease (%) 0 (0.0) 3 (18.8)
Cardiopathy (%) 4 (20.0) 2 (12.5)
Blood cell counts (%)
 Leukocytes (mean ± SD) 13.7 ± 4.9 9.2 ± 3.8 b
 Neutrophils (mean ± SD) 80.6 ± 6.1 71.4 ± 16.2 b
 Lymphocytes (mean ± SD) 10.7 ± 3.9 18.2 ± 12.7 b
 Monocytes (mean ± SD) 7.7 ± 2.6 8.4 ± 2.9
 Eosinophils (mean ± SD) 0.8 ± 0.8 1.6 ± 1.9
 Basophils (mean ± SD) 0.3 ± 0.2 0.4 ± 0.4
 Hematocrit (mean ± SD) 35.1 ± 6.1 39.5 ± 5.6 b
 Platelets (mean ± SD) 190.1 ± 74.2 250.4 ± 89.8 b
FEV1% (mean ± SD) NA 69.1 ± 31.1
FVC% (mean ± SD) NA 66.8 ± 28.2
FEV1/FVC% (mean ± SD) NA 75.0 ± 15.4
Inhaled/systemic corticosteroid treatment (%) NA 9 (56.3)
a

Average (range).

b

p < 0.05.

NA, non-available; SD, standard deviation.